The role of autophagy in RIP1 mediated cell death and intestinal inflammation.
| Autor: | Lee YM; Immunology Discovery, Genentech, South San Francisco, CA, United States., Vucic D; Immunology Discovery, Genentech, South San Francisco, CA, United States. Electronic address: domagoj@gene.com. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Advances in immunology [Adv Immunol] 2024; Vol. 163, pp. 1-20. Date of Electronic Publication: 2024 Aug 31. |
| DOI: | 10.1016/bs.ai.2024.07.003 |
| Abstrakt: | Autophagy, a highly conserved catabolic process that targets various types of cellular cargoes to lysosomal degradation, is one of the most important biological mechanisms critical for cellular homeostasis. Components of these cellular cargoes can range from individual proteins to invading pathogens, and degrading these materials is important for maintaining organismal health and survival. The process of autophagy is carried out by complex molecular mechanisms, and a growing body of evidence indicates that these mechanisms intersect with those involved in the cell death pathways. In this review, we examine several emerging studies elucidating the role of autophagy in RIP1-mediated cell death signaling, with particular emphasis on impaired autophagy caused by ATG16L1 deficiency. We also discuss how autophagy in RIP1-mediated cell death affects intestinal homeostasis in preclinical models, and the implications of the intersection between RIP1 and autophagy for understanding the intestinal pathologies associated with inflammatory bowel disease (IBD). Finally, we highlight the potential benefits of therapeutic targeting of RIP1 and autophagy proteins, while also proposing areas of research that will likely elucidate new links between autophagy and cell death signaling. (Copyright © 2024. Published by Elsevier Inc.) |
| Databáze: | MEDLINE |
| Externí odkaz: |
|